HUGO ID Detailed Result 7794


HUGO ID 7794
Symbol NFKB1
Name nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)
#Occurrence 34
#Paper 11

 


PMID Match String Actual String Score Flanking text Edited by Edit
14960605NF-kappaBNF-kappaB0.6et al. 2001 kappaB alpha inhibitory protein of nuclear factor-kappaB NF-kappaB (index index of NF-kappaB activity tumor necrosis factor-alpha TNF-alpha and 
14960605NF-kappaBNF-kappaB0.6alpha inhibitory protein of nuclear factor-kappaB NF-kappaB (index index of NF-kappaB activity tumor necrosis factor-alpha TNF-alpha and CD14 (data data not 
15081582NF-kappaBNF-kappaB0.3expression that is prevented in the presence of inhibitors of NF-kappaB (dexamethasone, dexamethasone the antioxidant pyrrolidine dithiocarbamate and the protein C 
15668976NF-kappaBNF-kappaB0.0-9 were upregulated whereas cell death inhibitors acetyl-CoA transporter and NF-kappaB were also upregulated 
17008387NF-kappaBNF-kappaB0.6dithiocarbamate (PDTC), PDTC an inhibitor of nuclear transcription factor kappa-B NF-kappaB and an antioxidant has beneficial effects in animal models of 
17008387NF-kappaBNF-kappaB0.6The DNA binding activity of NF-kappaB was not altered in G93A-SOD1 TG rats by PDTC treatment 
17008387NF-kappaBNF-kappaB0.6the treatment of AIDS (Reisinger Reisinger et al. 1990 kappa-B NF-kappaB that regulates the expression of several proinflammatory genes and some 
17008387NF-kappaBNF-kappaB0.6NF-kappaB activation may promote the expression of the genes that mediate 
17008387NF-kappaBNF-kappaB0.6cord samples showed no differences in DNA binding activity of NF-kappaB between PDTC and untreated groups ( Fig 2 
17008387NF-kappaBNF-kappaB0.6there was a trend toward increased DNA binding activity of NF-kappaB in G93A-SOD1 TG rats 
17008387NF-kappaBNF-kappaB0.6peripheral disease models by inhibiting the activation of transcription factor NF-kappaB serving as a strong antioxidant or by activating Akt-GSK3 beta 
17008387NF-kappaBNF-kappaB0.6Even though inhibition of NF-kappaB has frequently been associated with tissue and cellular protection inhibition 
17008387NF-kappaBNF-kappaB0.6frequently been associated with tissue and cellular protection inhibition of NF-kappaB may also accelerate neurodegeneration because of the survivalsupporting role of 
17008387NF-kappaBNF-kappaB0.6is possible that in a long-term disease such as ALS NF-kappaB activity even though being induced is not maintained at so 
17008387NF-kappaBNF-kappaB0.6does and thereby does not result in efficient inhibition of NF-kappaB In addition we cannot exclude the possibility that NF-kappaB binding 
17008387NF-kappaBNF-kappaB0.6of NF-kappaB In addition we cannot exclude the possibility that NF-kappaB binding to DNA is increased at time points other than 
17008387NF-kappaBNF-kappaB0.6experiments do not provide evidence for a central role of NF-kappaB in ALS 
17008387NF-kappaBNF-kappaB0.6In a previous study NF-kappaB immunoreactivity was found to be increased in astrocytes surrounding degenerating 
17008387NF-kappaBNF-kappaB0.6multipotent drug providing protection in various animal models by inhibiting NF-kappaB acting as an antioxidant and activating Akt-GSK3 beta pathway also 
17008387NF-kappaBNF-kappaB0.6showed no statistically significant differences in DNA binding activity of NF-kappaB between PDTC and untreated groups n = 5 results shown 
17008387NF-kappaBNF-kappaB0.6dithiocarbamate ALS amyotrophic lateral sclerosis EMSA electrophoretic mobility shift assay NF-kappaB nuclear factor kappaB SOD superoxide dismutase WT wild type TG 
17191135NFKBNFkB0.6Fos/Jun Fos Jun activator protein-1 (AP-1)], AP-1 nuclear factor-kB (NFkB) NFkB and the more recently identified Nrf2 proteins 24 -26 (Fig 
17191135NF-kBNF-kB0.6conferring constitutive expression inducible expression elements such as AP-1 AP-2 NF-kB Oct-1 PEA-3 Myb and the antioxidant-responsive element (ARE) ARE 71 
17191135NF-kBNF-kB0.6of critical transcription factors such as the AP-1 family members NF-kB Jun Fos p53 CREB PEBP2/CBF, PEBP2 CBF Myb all involved 
17969353NF-kappaBNF-kappaB0.5upregulated whereas cell death inhibitors acetyl-CoA transporter (ACATN) ACATN and NF-kappaB (NFKB) NFKB were also upregulated 
17969353NFKBNFKB0.5cell death inhibitors acetyl-CoA transporter (ACATN) ACATN and NF-kappaB (NFKB) NFKB were also upregulated 
18312546NF-kappaBNF-kappaB0.6protein kinase (p-p38) p-p38 and inhibitor of nuclear factor-kappaB (NF-kappaB)-alpha NF-kappaB -alpha (IkappaBalpha) IkappaBalpha in the spinal cords and compared the 
18312546NF-kappaBNF-kappaB-mediated0.6that pioglitazone protects motor neurons against p38-mediated neuronal death and NF-kappaB-mediated glial inflammation via a PPARgamma-independent mechanism 
14511332nf kappa bnf kappa b1.0nf kappa b. nf kappa b in particular is crucial for cox 2 induction in several cell types vane et al . 1998 and its activation has also been linked to neurodegeneration grilli _amp_ memo 1999 .  
15210305nf kappa bnf kappa b1.0immunohistochemical expression of a number of gene candidates including c jun jnk/sapk a kinase that exerts a stress related activation of c jun and nf kappa b a transcription factor induced by oxidative injury with a prominent neuroprotective function have been assayed in different disease targeted tissues.  
15210305nf kappa bnf kappa b1.0the jnk/sapk c jun pathway was found to be markedly up regulated [ 67 ] in als spinal cord astrocytes together with nf kappa b whereas motor neurones show a lower expression of these molecules.  
15649489nf kappa bnf kappa b1.0nf kappa b|neuroprotective agents|ppar gamma|thiazolidinediones|pioglitazone|3 nitrotyrosine|tyrosine|nitric oxide synthase|nitric oxide synthase type ii|nos2 protein mouse|sod1 g93a protein|superoxide dismutas 
17008387nf kappa bnf kappa b1.0the effect of pdtc was not mediated through nf kappa b inhibition.  
18464922nuclear factor kappa-bnuclear factor kappa b1.0several anti inflammatory mechanisms have been suggested including inhibition of nuclear factor kappa b nf _amp_#x003ba; b activator protein 1 ap 1 in addition to signal transducers and activators of transcription stat transcription factors by ppar _amp_#x003b3; [ 31 ].